DD201447A5 - Verfahren zur herstellung von als antikrebsmittel wirksamen immunoglobulin-konjugaten - Google Patents
Verfahren zur herstellung von als antikrebsmittel wirksamen immunoglobulin-konjugaten Download PDFInfo
- Publication number
- DD201447A5 DD201447A5 DD82236636A DD23663682A DD201447A5 DD 201447 A5 DD201447 A5 DD 201447A5 DD 82236636 A DD82236636 A DD 82236636A DD 23663682 A DD23663682 A DD 23663682A DD 201447 A5 DD201447 A5 DD 201447A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- immunoglobulin
- conjugate
- preparation
- cells
- vindesine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6805—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a vinca alkaloid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- External Artificial Organs (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8100847 | 1981-01-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD201447A5 true DD201447A5 (de) | 1983-07-20 |
Family
ID=10518931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD82236636A DD201447A5 (de) | 1981-01-12 | 1982-01-08 | Verfahren zur herstellung von als antikrebsmittel wirksamen immunoglobulin-konjugaten |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP0056322B1 (el) |
| JP (1) | JPS57136529A (el) |
| KR (1) | KR860001149B1 (el) |
| AT (1) | ATE16603T1 (el) |
| AU (1) | AU549495B2 (el) |
| BG (1) | BG40318A3 (el) |
| CA (1) | CA1180660A (el) |
| CS (1) | CS235525B2 (el) |
| DD (1) | DD201447A5 (el) |
| DE (1) | DE3267474D1 (el) |
| DK (1) | DK5982A (el) |
| EG (1) | EG15599A (el) |
| ES (1) | ES508633A0 (el) |
| FI (1) | FI820020L (el) |
| GB (1) | GB2090837B (el) |
| GR (1) | GR75182B (el) |
| HU (1) | HU186025B (el) |
| IE (1) | IE52239B1 (el) |
| IL (1) | IL64722A (el) |
| MX (1) | MX7215E (el) |
| NZ (1) | NZ199421A (el) |
| PH (1) | PH18031A (el) |
| PL (1) | PL128529B1 (el) |
| PT (1) | PT74252B (el) |
| RO (1) | RO82758B (el) |
| SU (1) | SU1069628A3 (el) |
| ZA (1) | ZA82122B (el) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4639456A (en) * | 1980-06-10 | 1987-01-27 | Omnichem S.A. | Vinblastin-23-oyl amino acid derivatives |
| CA1203164A (en) * | 1982-03-09 | 1986-04-15 | Thomas J. Mckearn | Antibody conjugates |
| DE3483336D1 (de) * | 1983-03-30 | 1990-11-08 | Lilly Industries Ltd | Vincaleukoblastin-derivate. |
| EP0121388B1 (en) * | 1983-03-30 | 1990-06-13 | Lilly Industries Limited | Immunoglobulin conjugates |
| GR81790B (el) * | 1983-04-29 | 1984-12-12 | Omnichem Sa | |
| GB2148299B (en) * | 1983-09-01 | 1988-01-06 | Hybritech Inc | Antibody compositions of therapeutic agents having an extended serum half-life |
| US4667030A (en) * | 1985-06-17 | 1987-05-19 | Eli Lilly And Company | Hydrazide succinimide derivatives of antineoplastic indole-dihydroindole alkaloids |
| US4675400A (en) * | 1985-06-17 | 1987-06-23 | Eli Lilly And Company | Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids |
| FI860456A (fi) * | 1985-07-16 | 1987-01-17 | Huhtamaeki Oy Laeaeketehdas Le | Bis-indolalkaloiders proteinkonjugat, bis-indolalkaloider, deras framstaellning och anvaendning. |
| EP0232693A3 (fr) * | 1985-12-16 | 1988-04-06 | La Region Wallonne | Conjugués de la vinblastine et de ses dérivés, procédé pour leur préparation et compositions pharmaceutiques les contenant |
| US4801688A (en) * | 1986-05-27 | 1989-01-31 | Eli Lilly And Company | Hydrazone immunoglobulin conjugates |
| IL82579A0 (en) * | 1986-05-27 | 1987-11-30 | Lilly Co Eli | Immunoglobulin conjugates |
| FR2626882B1 (fr) * | 1988-02-08 | 1991-11-08 | Ire Celltarg Sa | Conjugues de derives de vinca comportant une chaine detergente en position c-3 |
| US5144012A (en) * | 1988-08-08 | 1992-09-01 | Eli Lilly And Company | Cytotoxic drug conjugates |
| US5028697A (en) * | 1988-08-08 | 1991-07-02 | Eli Lilly And Company | Cytotoxic antibody conjugates of hydrazide derivatized methotrexate analogs via simple organic linkers |
| US5006652A (en) * | 1988-08-08 | 1991-04-09 | Eli Lilly And Company | Intermediates for antibody-vinca drug conjugates |
| US5094849A (en) * | 1988-08-08 | 1992-03-10 | Eli Lilly And Company | Cytotoxic antibody conjugates of hydrazide derivatized vinca analogs via simple organic linkers |
| US5043340A (en) * | 1990-04-03 | 1991-08-27 | Eli Lilly And Company | Derivatives of 4-desacetyl VLB C-3 carboxhydrazide |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2456224A1 (de) * | 1974-11-28 | 1976-08-12 | Karl Dr Med Theurer | Verwendung von nativen antikoerpern oder von antikoerper-fragmenten mit kovalent gebundenen oder konjugierten zytostatisch und/bzw. oder zytotoxisch wirkenden substanzen fuer die krebstherapie |
| GB1446536A (en) * | 1975-02-21 | 1976-08-18 | Yeda Res & Dev | Pharmaceutically active compositions |
| FR2349335A1 (fr) * | 1976-04-28 | 1977-11-25 | Inst Int Pathologie Cellulaire | Complexes d'alcaloides bis-indoliques du type vinblastine avec la tubuline, leur procede d'obtention et leur utilisation |
| EP0000938B1 (en) * | 1977-08-22 | 1984-10-17 | National Research Development Corporation | Macromolecular covalent conjugates, methods for preparing and pharmaceutical compositions containing them |
| FR2437213A1 (fr) * | 1978-09-28 | 1980-04-25 | Cm Ind | Produits cytotoxiques formes par liaison covalente de la chaine a de la ricine avec un anticorps et leur procede de preparation |
| JPS55136235A (en) * | 1979-04-09 | 1980-10-23 | Teijin Ltd | Antitumor protein complex and its preparation |
-
1982
- 1982-01-05 FI FI820020A patent/FI820020L/fi not_active Application Discontinuation
- 1982-01-06 EG EG8207A patent/EG15599A/xx active
- 1982-01-06 NZ NZ199421A patent/NZ199421A/en unknown
- 1982-01-07 IE IE23/82A patent/IE52239B1/en unknown
- 1982-01-07 RO RO105259A patent/RO82758B/ro unknown
- 1982-01-07 IL IL64722A patent/IL64722A/xx unknown
- 1982-01-07 PH PH26708A patent/PH18031A/en unknown
- 1982-01-07 PT PT74252A patent/PT74252B/pt unknown
- 1982-01-07 AU AU79274/82A patent/AU549495B2/en not_active Ceased
- 1982-01-08 DD DD82236636A patent/DD201447A5/de unknown
- 1982-01-08 BG BG054907A patent/BG40318A3/xx unknown
- 1982-01-08 DK DK5982A patent/DK5982A/da not_active Application Discontinuation
- 1982-01-08 ZA ZA82122A patent/ZA82122B/xx unknown
- 1982-01-11 DE DE8282300116T patent/DE3267474D1/de not_active Expired
- 1982-01-11 AT AT82300116T patent/ATE16603T1/de not_active IP Right Cessation
- 1982-01-11 JP JP57002635A patent/JPS57136529A/ja active Pending
- 1982-01-11 GB GB8200663A patent/GB2090837B/en not_active Expired
- 1982-01-11 CS CS82226A patent/CS235525B2/cs unknown
- 1982-01-11 ES ES508633A patent/ES508633A0/es active Granted
- 1982-01-11 HU HU8265A patent/HU186025B/hu unknown
- 1982-01-11 EP EP82300116A patent/EP0056322B1/en not_active Expired
- 1982-01-11 MX MX829866U patent/MX7215E/es unknown
- 1982-01-11 CA CA000393880A patent/CA1180660A/en not_active Expired
- 1982-01-11 SU SU823378149A patent/SU1069628A3/ru active
- 1982-01-12 PL PL1982234695A patent/PL128529B1/pl unknown
- 1982-01-12 GR GR66989A patent/GR75182B/el unknown
- 1982-01-12 KR KR8200104A patent/KR860001149B1/ko active
Also Published As
| Publication number | Publication date |
|---|---|
| PT74252A (en) | 1982-02-01 |
| DK5982A (da) | 1982-07-13 |
| CA1180660A (en) | 1985-01-08 |
| EG15599A (en) | 1986-06-30 |
| PL234695A1 (el) | 1982-07-19 |
| BG40318A3 (en) | 1986-11-14 |
| IL64722A0 (en) | 1982-03-31 |
| JPS57136529A (en) | 1982-08-23 |
| ATE16603T1 (de) | 1985-12-15 |
| PH18031A (en) | 1985-03-06 |
| IE52239B1 (en) | 1987-08-19 |
| RO82758B (ro) | 1984-01-30 |
| PL128529B1 (en) | 1984-02-29 |
| AU7927482A (en) | 1982-07-22 |
| EP0056322A1 (en) | 1982-07-21 |
| FI820020L (fi) | 1982-07-13 |
| KR860001149B1 (ko) | 1986-08-18 |
| ZA82122B (en) | 1983-07-27 |
| PT74252B (en) | 1983-08-24 |
| IE820023L (en) | 1982-07-12 |
| GR75182B (el) | 1984-07-13 |
| AU549495B2 (en) | 1986-01-30 |
| DE3267474D1 (en) | 1986-01-02 |
| KR830008684A (ko) | 1983-12-12 |
| RO82758A (ro) | 1984-01-14 |
| SU1069628A3 (ru) | 1984-01-23 |
| ES8304149A1 (es) | 1983-02-16 |
| ES508633A0 (es) | 1983-02-16 |
| HU186025B (en) | 1985-05-28 |
| GB2090837A (en) | 1982-07-21 |
| GB2090837B (en) | 1984-07-18 |
| MX7215E (es) | 1988-01-08 |
| EP0056322B1 (en) | 1985-11-21 |
| NZ199421A (en) | 1984-08-24 |
| CS235525B2 (en) | 1985-05-15 |
| IL64722A (en) | 1985-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD201447A5 (de) | Verfahren zur herstellung von als antikrebsmittel wirksamen immunoglobulin-konjugaten | |
| DE68912232T2 (de) | Konjugate zytotoxischer Arzneimittel. | |
| DE69430450T2 (de) | Zell- und serum- proteinanker und konjugate | |
| DE3853028T2 (de) | Antikörper-Enzym-Konjugate in Verbindung mit Wirkstoff-Vorläufern zur Freisetzung von cytotoxischen Mitteln in den Tumorzellen. | |
| DE69333800T2 (de) | Thioether enthaltende Konjugate | |
| DE3382572T2 (de) | Antikoerper-verbindungen. | |
| DE3852250T2 (de) | Über Thioetherbindungen verknüpfte Immunokonjugate, mit verminderter Toxizität und vermehrter Selektivität. | |
| DE69838953T2 (de) | Methoden zur herstellung von glykosylierten antikörpern und antikörperfragmenten mit reaktiven ketongruppen | |
| DE69614551T2 (de) | Verfahren zur herstellung von monomeren calicheamicinderivaten/trägerkonjugaten | |
| DE69131435T2 (de) | Bifunktionale Kupplungsverbindungen, Konjugate und Verfahren zu ihrer Herstellung | |
| DE3280408T2 (de) | Krebshemmende heilmittel fuer die behandlung von t-leukaemien, bestehend aus der a-kette des rizinus und einem spezifischen monoklonalen antikoerper. | |
| DE69103255T2 (de) | Säureempfindliche Linkermoleküle. | |
| DE3887675T2 (de) | Antikörper. | |
| DE69132055T2 (de) | Ortsgenaue konjugatbildung zwischen immunglobulinen und nachweisbaren markierungsstoffen | |
| DE3852054T2 (de) | Monoklonale Antikörper gegen Glycolipid-Antigene und ihre Verwendung. | |
| DE69029184T2 (de) | Hydrophile Derivate, diagnostische und therapeutische Anwendungen, diagnostische oder therapeutische Reagenziensätze und immunologische Reagenzien | |
| CH619614A5 (el) | ||
| DD204849A5 (de) | Verfahren zur herstellung von produkten fuer die behandlung von melanomen | |
| DE2910998A1 (de) | Verfahren zur herstellung von gebundenes enzym enthaltenden produkten und deren verwendung | |
| DE68927610T2 (de) | Antikörper-Arzneimittel Konjugale | |
| DE69032855T2 (de) | Antiidiotypischer antikörper, der eine immunantwort gegen ein glykosphingolipid induziert und seine verwendung | |
| DE2507901C2 (el) | ||
| DE69019959T2 (de) | Ortspezifische in-vivo-aktivierung von therapeutischen arzneimitteln. | |
| DE3851682T2 (de) | Targetformer von Antitumor-Methyltrithioagenzien. | |
| DE69032051T2 (de) | Targetformen von Antitumor-Methyltrithioagenzien |